Evogene Insider Trades
NASDAQ: EVGNIndustrialsAgricultural ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 3 · $692.78K
- Sales
- 0 · $0
- Shares bought / sold
- 1.26M / 0
- Net activity
- Net buying $692,777
Evogene insider activity
Over the last 12 months, Evogene insiders reported 3 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $692,777 and sold $0 worth of stock, for net insider buying of $692,777. The most recent filing shows RECANATI LEON (Director) buying 460,000 shares at $0.635 on Aug 11, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EVGN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
EVGN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 11, 2026 | RECANATI LEONDirector | Buy | 460,000 | $292.10K | Form 4 |
| Aug 4, 2026 | RECANATI LEONDirector | Buy | 800,000 | $400.00K | Form 4 |
| Jun 4, 2026 | Tarcic GabiChief Development Officer | Buy | 1,129 | $677.40 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4